These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26041296)

  • 1. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.
    Rathbun JY; Droniou ME; Damoiseaux R; Haworth KG; Henley JE; Exline CM; Choe H; Cannon PM
    J Virol; 2015 Aug; 89(16):8428-43. PubMed ID: 26041296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion.
    Torriani G; Trofimenko E; Mayor J; Fedeli C; Moreno H; Michel S; Heulot M; Chevalier N; Zimmer G; Shrestha N; Plattet P; Engler O; Rothenberger S; Widmann C; Kunz S
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
    Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
    J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.
    Lee AM; Rojek JM; Spiropoulou CF; Gundersen AT; Jin W; Shaginian A; York J; Nunberg JH; Boger DL; Oldstone MB; Kunz S
    J Biol Chem; 2008 Jul; 283(27):18734-42. PubMed ID: 18474596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse Genetics Approaches to Control Arenavirus.
    Martínez-Sobrido L; Cheng BY; de la Torre JC
    Methods Mol Biol; 2016; 1403():313-51. PubMed ID: 27076139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening for negative-stranded hemorrhagic fever viruses using reverse genetics.
    Wendt L; Bostedt L; Hoenen T; Groseth A
    Antiviral Res; 2019 Oct; 170():104569. PubMed ID: 31356830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.
    Wang P; Liu Y; Zhang G; Wang S; Guo J; Cao J; Jia X; Zhang L; Xiao G; Wang W
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899092
    [No Abstract]   [Full Text] [Related]  

  • 8. A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus.
    Thomas CJ; Casquilho-Gray HE; York J; DeCamp DL; Dai D; Petrilli EB; Boger DL; Slayden RA; Amberg SM; Sprang SR; Nunberg JH
    J Biol Chem; 2011 Feb; 286(8):6192-200. PubMed ID: 21159779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tangeretin, an extract from Citrus peels, blocks cellular entry of arenaviruses that cause viral hemorrhagic fever.
    Tang K; He S; Zhang X; Guo J; Chen Q; Yan F; Banadyga L; Zhu W; Qiu X; Guo Y
    Antiviral Res; 2018 Dec; 160():87-93. PubMed ID: 30339847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches in anti-arenaviral drug development.
    Lee AM; Pasquato A; Kunz S
    Virology; 2011 Mar; 411(2):163-9. PubMed ID: 21183197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform.
    Welch SR; Spengler JR; Genzer SC; Chatterjee P; Flint M; Bergeron É; Montgomery JM; Nichol ST; Albariño CG; Spiropoulou CF
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34203149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel drug discovery approaches for treating arenavirus infections.
    Pasquato A; Kunz S
    Expert Opin Drug Discov; 2016; 11(4):383-93. PubMed ID: 26882218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifecycle modelling systems support inosine monophosphate dehydrogenase (IMPDH) as a pro-viral factor and antiviral target for New World arenaviruses.
    Dunham EC; Leske A; Shifflett K; Watt A; Feldmann H; Hoenen T; Groseth A
    Antiviral Res; 2018 Sep; 157():140-150. PubMed ID: 30031760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
    Martinez-Sobrido L; de la Torre JC
    Expert Rev Vaccines; 2016 Sep; 15(9):1113-21. PubMed ID: 27118328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
    Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
    J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.
    Ortiz-Riaño E; Ngo N; Devito S; Eggink D; Munger J; Shaw ML; de la Torre JC; Martínez-Sobrido L
    J Virol; 2014 Jan; 88(2):878-89. PubMed ID: 24198417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse genetics approaches to combat pathogenic arenaviruses.
    de la Torre JC
    Antiviral Res; 2008 Dec; 80(3):239-50. PubMed ID: 18782590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current drug discovery strategies against arenavirus infections.
    Pasquato A; Burri DJ; Kunz S
    Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1297-309. PubMed ID: 23241187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Reverse Genetics for the Prototype New World Mammarenavirus Tacaribe Virus.
    Ye C; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials.
    Olschläger S; Flatz L
    PLoS Pathog; 2013; 9(4):e1003212. PubMed ID: 23592977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.